Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation

Cardiovasc Res. 1999 May;42(2):434-42. doi: 10.1016/s0008-6363(99)00036-x.

Abstract

Background: We have shown that rapid atrial activation, as occurs during atrial fibrillation (AF), reduces L-type Ca2+ current (ICa) and that this is the principal mechanism of the action potential duration and refractoriness changes that characterize tachycardia-induced atrial remodeling. The present study was designed to determine whether atrial tachycardia alters biochemical indices of the number of L-type Ca2+ channels and/or of the number and binding affinity of beta-adrenergic receptors.

Methods: In canine atrial sarcolemmal preparations, the number and binding affinity of dihydropyridine receptors were determined with the use of 3H-nitrendipine and that of beta-adrenergic receptors with 125I-iodocyanopindolol. Results were obtained with preparations from dogs paced at 400/min for 1 (P1, n = 20), 7 (P7, n = 9), and 42 (P42, n = 9) days, and compared with observations in sham-operated controls (P0, n = 14).

Results: Pacing reduced the Bmax of dihydropyridine receptors, from 157 +/- 18 fmol/mg (P0) to 116 +/- 9 fmol/mg (P1, P < 0.05), 100 +/- 14 fmol/mg (P7, P < 0.05) and 94 +/- 9 fmol/mg (P42, P < 0.01). The affinity of dihydropyridine receptors was unchanged, with the Kd averaging 711 +/- 102 pM. 656 +/- 74 pM, 633 +/- 155 pM and 585 +/- 92 pM in P0, P1, P7 and P42 dogs. Neither Bmax nor Kd of beta-adrenergic receptors was altered by rapid pacing. Values of Bmax of dihydropyridine receptors correlated with atrial ICa current density (r2 = 0.95) and ERP (r2 = 0.99).

Conclusions: Rapid atrial activation results in downregulation in the number of dihydropyridine receptors without altering the number or affinity of beta-adrenergic receptors. The reductions in ICa that play an important role in the atrial electrical remodeling by which 'AF begets AF' appear to be due at least in part to a decrease in the number of L-type Ca2+ channels in cardiac cell membranes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology
  • Analysis of Variance
  • Animals
  • Atrial Fibrillation / metabolism*
  • Binding Sites
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / metabolism*
  • Cardiac Pacing, Artificial
  • Dihydropyridines / metabolism*
  • Dogs
  • Female
  • Iodocyanopindolol / pharmacology
  • Linear Models
  • Male
  • Myocardium / metabolism*
  • Nitrendipine / pharmacology
  • Receptors, Adrenergic, beta / metabolism*
  • Sarcolemma / metabolism
  • Statistics, Nonparametric

Substances

  • Adrenergic beta-Antagonists
  • Calcium Channel Blockers
  • Calcium Channels
  • Dihydropyridines
  • Receptors, Adrenergic, beta
  • Iodocyanopindolol
  • Nitrendipine
  • Calcium